AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
12:22 EDT 17 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
LOS ALTOS, Calif., Aug. 17, 2012 /PRNewswire-iReach/ -- AbGenomics International announced today that it has obtained agreement from U.S. Food and Drug Administration (FDA) for its proposed plans for a phase 2 clinical trial of the novel autoimmune therape...
Other Sources for this Article
More From BioPortfolio on "AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
